home / stock / seer / seer news

SEER News and Press, Seer Inc. From 07/12/23

Stock Information
Company Name: Seer Inc.
Stock Symbol: SEER
Market: NASDAQ
Website: seer.bio
Menu
SEER SEER Quote SEER Short SEER News SEER Articles SEER Message Board
Get SEER Alerts

News, Short Squeeze, Breakout and More Instantly...
SEER - Seer Grows From A Small Base But Sales Cycles Slow

2023-07-12 14:09:52 ET Summary Seer sells an integrated proteomics analysis system to biopharma firms and academic researchers. The firm's revenue growth is high from a small base and it is generating high and worsening operating losses. With sales cycles lengthening, I'm Neut...
SEER - TRUP, SDIG and KNTE are among after hour movers

2023-06-22 17:31:01 ET Gainers: Trupanion ( TRUP ) +15% . Stronghold Digital Mining ( SDIG ) +6% . Pinduoduo ( PDD ) +6% . CareMax ( CMAX ) +5% . Seer ( SEER ) +4% . Losers: Kinnate Biopharma ( KNTE ) -5% . Ca...

SEER - Iran oil exports hit five-year highs with U.S. reportedly in negotiations

2023-06-16 20:05:22 ET Crude oil exports out of Iran have surged to five-year highs despite U.S. sanctions, signaling something of a resurgence for the country on the world stage but also sapping confidence in an oil market already weakened by lackluster global economic growth and cheap...

SEER - Seer Collaborates to Make Scalable, Unbiased Proteomics Accessible to More Researchers via new Seer Technology Access Center

REDWOOD CITY, Calif., June 07, 2023 (GLOBE NEWSWIRE) -- Seer, Inc . (NASDAQ: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced an expanded collaboration with Thermo Fisher Scientific, a world leader in serving science, to enab...
SEER - Seer Launches the Proteograph XT Assay Kit: Allowing Labs to Easily Expand Their View of the Proteome and Scale Their Studies

REDWOOD CITY, Calif., June 01, 2023 (GLOBE NEWSWIRE) -- Seer Inc. (NASDAQ: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced the launch of the Proteograph XT Assay Kit , the latest proteomics assay workflow for the Proteograph Product Sui...

SEER - Seer GAAP EPS of -$0.38 beats by $0.01, revenue of $4.05M beats by $0.13M

2023-05-09 16:47:48 ET Seer press release ( NASDAQ: SEER ): Q1 GAAP EPS of -$0.38 beats by $0.01 . Revenue of $4.05M (+22.4% Y/Y) beats by $0.13M . Seer continues to expect full year 2023 revenue to be in the range of $23 million to $25 million vs $23.95M conse...

SEER - Seer Reports First Quarter 2023 Financial Results

Grew revenue 22% year-over-year with continued growth in installed base and an increasing number of customer presentations and publications REDWOOD CITY, Calif., May 09, 2023 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new pl...
SEER - Seer to Report First Quarter 2023 Financial Results on May 9, 2023

REDWOOD CITY, Calif., April 20, 2023 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced that it will report financial results for the first quarter of 2023 after market close on Tuesday, May 9, 2023. Com...

SEER - Seer's Proteograph(TM) Product Suite identifies undiscovered links between protein variants and lung cancer progression

REDWOOD CITY, Calif., March 29, 2023 (GLOBE NEWSWIRE) -- Seer Inc. (NASDAQ: SEER), a life sciences company commercializing a disruptive new platform for proteomics, today announced a new scientific publication in PLOS One demonstrating the unmatched utility of the Proteograph Product Suit...

SEER - Altamira, Bullfrog top healthcare gainers; Praxis, Veru lead losers' pack

Gainers: Altamira Therapeutics ( CYTO ) +86% . Bullfrog AI ( BFRG ) +26% . Seer ( SEER ) +25% . Ardelyx ( ARDX ) +23% . Lucy Scientific Discovery ( LSDI ) +16% . Losers: Praxis Precision Medicines ( PRAX ) -55% . Veru (...
Previous 10 Next 10